Exclusive

Publication

Byline

Rackspace Appoints Pranav Nambiar To Lead AI Infrastructure

New Delhi, Aug. 7 -- Rackspace Technology has appointed Pranav Nambiar, Senior Vice President and General Manager, AI Infrastructure, Rackspace Technology, to lead its AI infrastructure business. The ... Read More


India sees 68 major renewable sector grid disturbances, generation losses of up to 7 GW

India, Aug. 7 -- India recorded 68 major disturbances in renewable energy sector complexes between January 2022 and June 2025, with generation losses ranging from 1gigawatt (GW) to 7 GW in individual ... Read More


MNRE weighs support scheme for polysilicon to back 10 GW capacity in solar manufacturing

India, Aug. 7 -- The Union Ministry of New and Renewable Energy is working on a Production Linked Incentive scheme to support domestic polysilicon manufacturing, a senior official said. India has mor... Read More


AI adoption in India's power generation sector to rise 65 per cent by 2030: ENCIS survey

India, Aug. 7 -- AI is poised to become a core capability in India's power generation, with adoption expected to rise 65 per cent by 2030, up from 35 per cent today, an ENCIS survey shows. Covering 2... Read More


QIMR Berghofer and James Cook University to advance tropical health research and workforce development in Australia

Singapore, Aug. 7 -- QIMR Berghofer and James Cook University (JCU) have strengthened their strategic partnership to create one of Australia's leading collaborations in tropical health research, accel... Read More


Energenesis Biomedical partners with Taiwan Tanabe Seiyaku to develop topical drug for diabetic foot ulcers

Singapore, Aug. 7 -- Energenesis Biomedical has entered into a joint development agreement with Taiwan Tanabe Seiyaku, the wholly owned subsidiary of Tanabe Pharma Corporation, for ENERGI-F703DFU, Ene... Read More


Moderna receives US FDA approval for influenza vaccine mFLUSIVA

Singapore, Aug. 7 -- Moderna, Inc. has announced that the US Food and Drug Administration (FDA) has approved mFLUSIVA(R) (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50... Read More


Singapore's Hilleman Labs to develop and produce CEPI-backed Bundibugyo ebolavirus vaccine doses for clinical trials

Singapore, Aug. 7 -- Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is collaborating with Hilleman Laboratories, a Singapore-based joint venture of biopharmaceutical company MSD a... Read More


Northwest Biotherapeutics announces MoU with Saudi Pharmaceutical Industries and Medical Appliance Company

Singapore, Aug. 7 -- Northwest Biotherapeutics, a US-based biotechnology company developing DCVax(R) personalised immune therapies for solid tumour cancers, has entered into a non-binding Memorandum o... Read More


"Health workforce training is a big area as there are shortages in Australia and India"

Singapore, Aug. 7 -- How are Australia-India health partnerships driving innovations in the non-communicable diseases sector? We have had a number of partnerships in diabetes research with CMC Vellor... Read More